Provided by Tiger Trade Technology Pte. Ltd.

NEUROGENE INC

37.87
+1.634.50%
Post-market: 37.870.00000.00%16:29 EDT
Volume:134.48K
Turnover:5.03M
Market Cap:757.83M
PE:-7.51
High:38.21
Open:35.80
Low:35.31
Close:36.24
52wk High:43.66
52wk Low:15.93
Shares:20.01M
Float Shares:11.34M
Volume Ratio:0.62
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0440
EPS(LYR):-4.2400
ROE:-45.32%
ROA:-27.97%
PB:3.49
PE(LYR):-8.93

Loading ...

Neurogene price target raised to $81 from $69 at Guggenheim

TIPRANKS
·
Aug 17

Neurogene price target lowered to $166 from $180 at Canaccord

TIPRANKS
·
Aug 17

Stifel Nicolaus Sticks to Their Buy Rating for Neurogene (NGNE)

TIPRANKS
·
Aug 13

Neurogene Price Target Raised to $81.00/Share from $69.00 by Guggenheim

Dow Jones
·
Aug 12

Annexon Biosciences Q2 Net Loss Widens, Cash Runway Extended

Reuters
·
Aug 12

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

TIPRANKS
·
Aug 12

Savara Q2 Loss Widens as Operating Expenses Rise

Reuters
·
Aug 12

Neurogene Inc : Canaccord Genuity Cuts Target Price to $166 from $180

THOMSON REUTERS
·
Aug 11

Neurogene Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Neurogene Q2 Operating Expenses USD 36.67 Million

Reuters
·
Aug 11

Neurogene Q2 EPS $(1.53) Misses $(1.39) Estimate

Benzinga Earnings
·
Aug 11

Neurogene Publishes Corporate Presentation Highlighting NGN-401 Gene Therapy Program for Rett Syndrome

Reuters
·
Aug 11

Neurogene Q2 Adjusted Loss Per Share Misses Estimates on Employee Costs

Reuters
·
Aug 11

Neurogene Q2 FY26 Net Loss Widens to USD 34.49 Million

Reuters
·
Aug 11

Neurogene Q2 Adjusted EPS USD -1.53 VS. Ibes Estimate USD -1.42

THOMSON REUTERS
·
Aug 11

Neurogene - Extends Cash Runway into Q1 2029 with $144 Mln Oversubscribed Financing

THOMSON REUTERS
·
Aug 11

Corrected-Neurogene Q2 EPS USD -1.53 (Removes Extraneous Word)

THOMSON REUTERS
·
Aug 11

Press Release: Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates

Dow Jones
·
Aug 11

Neurogene Inc Expected to Post a Loss of $1.42 a Share - Earnings Preview

Reuters
·
Aug 07